Neural Regeneration Research, 2024 · DOI: https://doi.org/10.4103/1673-5374.380881 · Published: March 1, 2024
This review discusses the relationship between gut microbiota and spinal cord injury (SCI). It highlights that SCI patients often experience intestinal dysfunction and gut dysbiosis, which can hinder recovery due to neurogenic inflammatory responses. The review identifies key factors contributing to gut dysbiosis in SCI patients, including weakened intestinal peristalsis, immune dysfunction, and frequent antibiotic use. These factors disrupt the balance of the gut microbiota. It also explores potential mechanisms through which the gut microbiota and its metabolites affect recovery after SCI, such as the cytokine and Toll-like receptor ligand pathways. Therapies like fecal microbiota transplantation and probiotics show promise.
Therapies targeting the gut microbiota, such as fecal microbiota transplantation, probiotics, and dietary interventions, hold promise for promoting functional recovery and improving complications after SCI.
Using the characteristic gut microbiota as a biological marker to diagnose and evaluate SCI may improve the efficiency and accuracy of both diagnosis and treatment.
Understanding the dual role of TLRs and the NLRP3 inflammasome can inform the design of further studies to enhance beneficial effects and reduce deleterious effects in SCI patients.